Your browser doesn't support javascript.
loading
Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma.
Potter, Samara L; Reuther, Jacquelyn; Chandramohan, Raghu; Gandhi, Ilavarasi; Hollingsworth, Faith; Sayeed, Hadi; Voicu, Horatiu; Kakkar, Nipun; Baksi, Koel Sen; Sarabia, Stephen F; Lopez, Monica E; Chelius, Daniel C; Athanassaki, Ioanna D; Mahajan, Priya; Venkatramani, Rajkumar; Quintanilla, Norma M; Lopez-Terrada, Dolores H; Roy, Angshumoy; Parsons, D Williams.
Afiliación
  • Potter SL; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
  • Reuther J; Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.
  • Chandramohan R; Department of Pathology, Texas Children's Hospital, Houston, Texas.
  • Gandhi I; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
  • Hollingsworth F; Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.
  • Sayeed H; Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.
  • Voicu H; Department of Pathology, Texas Children's Hospital, Houston, Texas.
  • Kakkar N; Department of Pathology, Texas Children's Hospital, Houston, Texas.
  • Baksi KS; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
  • Sarabia SF; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
  • Lopez ME; Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.
  • Chelius DC; Department of Surgery, Texas Children's Hospital, Houston, Texas.
  • Athanassaki ID; Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.
  • Mahajan P; Department of Surgery, Texas Children's Hospital, Houston, Texas.
  • Venkatramani R; Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.
  • Quintanilla NM; Department of Otolaryngology, Baylor College of Medicine, Houston, Texas.
  • Lopez-Terrada DH; Pediatric Endocrinology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas.
  • Roy A; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
  • Parsons DW; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
Pediatr Blood Cancer ; 68(1): e28741, 2021 01.
Article en En | MEDLINE | ID: mdl-33009870
BACKGROUND: Pediatric papillary thyroid carcinoma (PTC) is clinically and biologically distinct from adult PTC. We sequenced a cohort of clinically annotated pediatric PTC cases enriched for high-risk tumors to identify genetic alterations of relevance for diagnosis and therapy. METHODS: Tumor DNA and RNA were extracted from FFPE tissue and subjected to next-generation sequencing (NGS) library preparation using a custom 124-gene hybridization capture panel and the 75-gene Archer Oncology Research Panel, respectively. NGS libraries were sequenced on an Illumina MiSeq. RESULTS: Thirty-six pediatric PTC cases were analyzed. Metastases were frequently observed to cervical lymph nodes (29/36, 81%), with pulmonary metastases less commonly found (10/36, 28%). Relapsed or refractory disease occurred in 18 patients (18/36, 50%). DNA sequencing revealed targetable mutations in 8 of 31 tumors tested (26%), most commonly BRAF p.V600E (n = 6). RNA sequencing identified targetable fusions in 13 of 25 tumors tested (52%): RET (n = 8), NTRK3 (n = 4), and BRAF. Mutually exclusive targetable alterations were discovered in 15 of the 20 tumors (75%) with both DNA and RNA analyzed. Fusion-positive PTC was associated with multifocal disease, higher tumor staging, and higher American Thyroid Association risk levels. Both BRAF V600E mutations and gene fusions were correlated with the presence of cervical metastases. CONCLUSIONS: Targetable alterations were identified in 75% of pediatric PTC cases with both DNA and RNA evaluated. Inclusion of RNA sequencing for detection of fusion genes is critical for evaluation of these tumors. Patients with fusion-positive tumors were more likely to have features of high-risk disease.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ADN de Neoplasias / Neoplasias de la Tiroides / Carcinoma Papilar / Biomarcadores de Tumor / Análisis de Secuencia de ARN / Neoplasias Pulmonares / Mutación Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ADN de Neoplasias / Neoplasias de la Tiroides / Carcinoma Papilar / Biomarcadores de Tumor / Análisis de Secuencia de ARN / Neoplasias Pulmonares / Mutación Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos